PRESS RELEASE published on 03/25/2026 at 07:20, 6 months 13 days ago CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory CROSSJECT publishes its 2025 financial results, showing improved operating revenue and net loss. Strengthening operational, industrial, and financial trajectory highlighted for ZEPIZURE® and ZENEO® platform development Financial Results Net Loss Operating Revenue Crossject ZEPIZURE®
BRIEF published on 11/14/2025 at 20:51, 10 months 22 days ago CROSSJECT finalise un accord de financement de 5 millions d'euros avec Vatel Capital Obligations Convertibles ZEPIZURE® Financement De 5 Millions D'euros CROSSJET Capitale Vatel
BRIEF published on 11/14/2025 at 20:51, 10 months 22 days ago CROSSJECT Completes €5 Million Financing Deal with Vatel Capital Convertible Bonds Crossject ZEPIZURE® Vatel Capital €5 Million Financing
PRESS RELEASE published on 11/14/2025 at 20:46, 10 months 22 days ago CROSSJECT completes €5 million financing with Vatel Capital CROSSJECT announces completion of €5 million financing with Vatel Capital through convertible bonds for ZEPIZURE® development. Funds to support regulatory activities for emergency use authorization application Financing Convertible Bonds Crossject ZEPIZURE® Vatel Capital
PRESS RELEASE published on 11/14/2025 at 20:46, 10 months 22 days ago CROSSJECT lève 5 millions d'euros auprès de Vatel Capital CROSSJECT lève 5 millions d'euros auprès de Vatel Capital pour son auto-injecteur ZENEO et injectable ZEPIZURE. Opération de 3 tranches d'Obligations Convertibles avec intérêts de 7,5% à 9,5% sur 3 à 5 ans Obligations Convertibles Crossject ZEPIZURE ZENEO Vatel Capital
BRIEF published on 09/24/2025 at 22:05, 1 year ago CROSSJECT Reports First Half of 2025 Financial Results and Updates Financial Results Crossject ZEPIZURE® BARDA Regulatory Progress
BRIEF published on 09/24/2025 at 22:05, 1 year ago CROSSJECT publie ses résultats financiers et ses mises à jour du premier semestre 2025 Résultats Financiers Crossject ZEPIZURE® BARDA Progrès Réglementaires
PRESS RELEASE published on 09/24/2025 at 22:00, 1 year ago CROSSJECT presents its financial results and key highlights for the first half of 2025 CROSSJECT announces financial results and business highlights for H1 2025, including cash position, R&D investments, BARDA reimbursements, and progress towards ZEPIZURE® registration Financial Results R&D Investments Crossject ZEPIZURE® BARDA
PRESS RELEASE published on 09/24/2025 at 22:00, 1 year ago CROSSJECT présente ses résultats financiers et les principaux faits marquants pour le premier semestre 2025 CROSSJECT annonce ses résultats financiers pour le premier semestre 2025 et l'avancement de ZEPIZURE®. Nouveaux investissements, extension du financement R&D et progression vers l'autorisation d'utilisation d'urgence Résultats Financiers Crossject ZEPIZURE BARDA Premier Semestre 2025
BRIEF published on 09/22/2025 at 07:35, 1 year ago Additional funding for CROSSJECT from BARDA FDA Funding Crossject ZEPIZURE® BARDA
Published on 10/07/2026 at 17:00, 1 hour 50 minutes ago BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 3 hours 20 minutes ago Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 4 hours 20 minutes ago Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/07/2026 at 13:33, 5 hours 17 minutes ago BULGOLD Samples 21.2g/t Gold at Surface and Expands Kopernica Footprint by 170% to 1,700 Metres by 800 Metres, Lutila Project
Published on 10/07/2026 at 13:00, 5 hours 50 minutes ago ATHA Energy Successfully Completes Diamond Drilling at RIB North Discovery, Expanding Strike Length To 3.4 Km, And Identifies a Higher-Grade Sub Zone: Results Include RIBN-DD-023 Intersecting 19.5 M Of Composite Uranium Mineralization With 2.0 M Of High-G
Published on 10/07/2026 at 18:30, 20 minutes ago IEVA GROUP: rappel – Visioconference actionnaires et investisseurs jeudi 15 octobre 2026 - 18h00 (CEST)
Published on 10/07/2026 at 18:15, 35 minutes ago VAZIVA SA: 2026 HALF-YEAR RESULTS - A half-year of strategic investments to prepare a new growth cycle
Published on 10/07/2026 at 18:00, 50 minutes ago EUROPLASMA: Réduction de capital et regroupement des actions Europlasma
Published on 10/07/2026 at 17:44, 1 hour 6 minutes ago BILENDI: Half-year 2026 Results: Continued execution of the strategic plan in a challenging market environment
Published on 10/07/2026 at 17:44, 1 hour 6 minutes ago BILENDI: Résultats semestriels 2026 : Poursuite de l’exécution du plan stratégique dans un environnement de marché exigeant
Published on 10/07/2026 at 18:19, 30 minutes ago Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 18:19, 30 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 30 septembre 2026
Published on 10/07/2026 at 18:00, 50 minutes ago Mint organise une visioconférence pour annoncer ses résultats semestriels 2026.
Published on 10/07/2026 at 18:00, 50 minutes ago Cegedim Assurances et Shift Technology fêtent 5 ans de partenariat et intègrent WTW au sein de leur dispositif commun de lutte contre la fraude